OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 17 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $27,000 | +285.7% | 100,000 | +334.8% | 0.00% | – |
| Q2 2016 | $7,000 | -12.5% | 23,000 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -42.9% | 23,000 | 0.0% | 0.00% | – |
| Q4 2015 | $14,000 | -12.5% | 23,000 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | -23.8% | 23,000 | 0.0% | 0.00% | – |
| Q2 2015 | $21,000 | -98.2% | 23,000 | -97.7% | 0.00% | – |
| Q1 2015 | $1,152,000 | +15.9% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2014 | $994,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $3,550,000 | 0.43% |
| Telemetry Investments, L.L.C. | 2,500,000 | $875,000 | 0.33% |
| UBS OCONNOR LLC | 7,500,000 | $2,780,000,000 | 0.05% |